ENZON PHARMACEUTICALS, INC. 10-K Cybersecurity GRC - 2024-03-20

Page last updated on April 22, 2024

ENZON PHARMACEUTICALS, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-20 16:06:43 EDT.

Filings

10-K filed on 2024-03-20

ENZON PHARMACEUTICALS, INC. filed an 10-K at 2024-03-20 16:06:43 EDT
Accession Number: 0001410578-24-000245

Item 1C. Cybersecurity.

As we have positioned ourselves as a public company acquisition vehicle, and have limited operations, we do not have any significant operations that face cybersecurity threats. Although we do depend on the digital technologies of third parties, and any deliberate attacks on, or security breaches in, systems or infrastructure that we utilize, including those of third parties, could lead to corruption or misappropriation of our assets, information and sensitive or confidential data, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if there is any. In fiscal year 2023, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition.


Company Information

NameENZON PHARMACEUTICALS, INC.
CIK0000727510
SIC DescriptionBiological Products, (No Diagnostic Substances)
TickerENZN - OTC
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30